NCT02670473

Brief Summary

The aim of this dispensing study is to evaluate the clinical performance of habitual wearers of enfilcon A lenses following a refit with fanfilcon A lenses over 4 weeks of daily wear.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

January 28, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 1, 2016

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
11 months until next milestone

Results Posted

Study results publicly available

March 21, 2017

Completed
Last Updated

February 5, 2018

Status Verified

July 1, 2017

Enrollment Period

2 months

First QC Date

January 28, 2016

Results QC Date

January 30, 2017

Last Update Submit

July 18, 2017

Conditions

Outcome Measures

Primary Outcomes (4)

  • Lens Fit - Centration

    Lens fit evaluation of centration for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale: optimum, decentration acceptable, decentration unacceptable.

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Lens Fit - Post-blink Movement

    Lens fit evaluation of post-blink movement for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale 0-5 Likert scale, 0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement.

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Lens Tightness on Push-up

    Lens fit evaluation of tightness on push-up test for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale: 0%-100%, 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement.

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Overall Fit Acceptance

    Overall fit acceptance for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimum acceptable, early review, 3=Not perfect but okay to dispense, 4=Perfect.

    Baseline, 1 week, 2 weeks, and 4 weeks

Secondary Outcomes (9)

  • Overall Comfort

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Dryness Overall

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Handling

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Overall Vision Satisfaction

    Baseline, 1 week, 2 weeks, and 4 weeks

  • Overall Satisfaction

    Baseline, 1 week, 2 weeks, and 4 weeks

  • +4 more secondary outcomes

Study Arms (2)

enfilcon A (habitual)

NO INTERVENTION

Participants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.

fanfilcon A (test)

EXPERIMENTAL

Participants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.

Device: fanfilcon A (test)

Interventions

contact lens

fanfilcon A (test)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Is between 18 and 40 years of age
  • Has had a self-reported visual exam in the last two years
  • Is an adapted enfilcon A contact lens wearer (at least 2 weeks in enfilcon A lens)
  • Has a contact lens spherical prescription between -1.00 to - 6.00
  • Has a spectacle cylinder up to 0.75D (Diopters) in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood, and signed the information consent letter.
  • Patient contact lens refraction should fit within the available parameters of the study lenses.
  • Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so).
  • Is willing to comply with the visit schedule

You may not qualify if:

  • A person will be excluded from the study if he/she:
  • Is not a habitual wearer of enfilcon A lenses
  • Has a CL (Contact Lens) prescription outside the range of the available parameters of the study lenses.
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.
  • Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day)
  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
  • Presence of clinically significant (grade 3-4) anterior segment abnormalities
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization \> 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, Seborrheic conjunctivitis
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Optometry Research Group (GIO) Optics Department, University of Valencia

Valencia, 46100, Spain

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Senior Manager Global Medical Scientific Affairs
Organization
CooperVision Inc.

Study Officials

  • Robert Montés-Mico, O.D., PhD

    Optometry Research Group (GIO) University of Valencia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2016

First Posted

February 1, 2016

Study Start

January 1, 2016

Primary Completion

March 1, 2016

Study Completion

May 1, 2016

Last Updated

February 5, 2018

Results First Posted

March 21, 2017

Record last verified: 2017-07

Locations